메뉴 건너뛰기

Takeda to Present at the 34th Annual J.P. Morgan Healthcare Conference

2016-01-12 17:00
Takeda Pharmaceutical Company Limited 제공

OSAKA, JAPAN--(Business Wire/Korea Newswire) January 12, 2016 -- Takeda Pharmaceutical Company Limited (TOKYO: 4502) (http://goo.gl/eX9kbP) (“Takeda”) today announced that Christophe Weber, President and Chief Executive Officer of Takeda, will make a formal presentation on January 12, local time, at the 34th Annual J.P. Morgan Healthcare Conference held in San Francisco, California. The presentation will be followed by a Q&A session.

Details of the timing, and how to access the audio webcast and presentation materials, are as follows.

Date and time
Tuesday January 12, at 11:30am - 12:30pm (Pacific Standard Time)
[Wednesday January 13, at 4:30am - 5:30am (Japan Standard Time)]

Agenda
· Presentation (25 minutes): Takeda Strategic Update
Christophe Weber, President and Chief Executive Officer
(Note: Includes updates on ENTYVIO® sales from Oct-Dec 2015, and Takeda's direction in R&D)

· Q&A session (25 minutes)
Christophe Weber, President and Chief Executive Officer
Andrew Plump, Chief Medical & Scientific Officer
Rudolf van Houten, acting Chief Financial Officer
Christophe Bianchi, President, Global Oncology Business Unit

Access to audio webcast
http://bit.ly/1TH6bTS
· Registration is required in advance, so please visit the URL a few minutes before the presentation is scheduled to begin.
· In addition to a live webcast, the audio will also be available on-demand at this URL for 90 days following the event.

Access to presentation materials
Presentation materials will be uploaded to Takeda's website at the same time as the presentation begins:
http://bit.ly/1O6KRFX

Note: Audio and materials are available only in English.

About Takeda Pharmaceutical Company Limited

Located in Osaka, Japan, Takeda (TOKYO: 4502) (http://goo.gl/eX9kbP) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160107006438/en/

News Source: Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited

Media Contacts:
Tsuyoshi Tada
+81 3-3278-2417
tsuyoshi.tada@takeda.com

Investor Contacts:
Noriko Higuchi
+81 3-3278-2306
noriko.higuchi@takeda.com

이 뉴스는 기업·기관이 발표한 보도자료 전문입니다. 언론 매체와 블로거는 보도를 목적으로 이 보도자료를 사용할 수 있습니다.

이전화면

보도자료를 발표할 생각이세요?

뉴스와이어는 국내 최강의 보도자료
배포 플랫폼입니다.

무료 가입하기

서비스 개요

회원이세요? 로그인